Hepatitis C Pharmacist, Physician, Patient Navigator Collaborative Care Model in Permanent Supportive Housing

Summary

The objective of this study is to extend our prior research by conducting a pragmatic implementation trial using a parallel-group, cluster randomized design to evaluate the PPP-CCM's ability to improve access to DAAs for HCV within a network of permanent supportive housing (PSH) buildings in Seattle and King County. The study will implement PPP-CCM to 16 housing buildings, randomizing half to receive PPP-CCM (intervention) versus usual care (UC) for 12-months, after which all buildings will have access to PPP-CCM. All buildings will have access to point-of-care HCV screening for the first 6 months of the study. Study outcome data will be collected through a longitudinal cohort-study of persons who screened positive for HCV which will conduct surveys and review of medical records at baseline, 12- and 24-months.

Eligibility

Inclusion Criteria:

* Adult ≥18 years of age
* Currently a resident at one of DESC's PSH buildings at the time of study enrollment
* Positive HCV test documented (screening antibody test or viral load test)
* Provides release of information (ROI) to access community pharmacy electronic medical records (EHR) and/or other HCV treatment providers for information on HCV care during the study period between baseline visit and 24-month visit

Exclusion Criteria:

* Taking medications to treat HCV at the start of the study
* Cognitive impairment (acute or chronic) resulting in inability to provide informed consent
* Currently or impending incarceration
* People who plan to leave the Seattle area within 24 months
* Not English speaking
* Behavioral risk posing safety concerns per discretion of research staff

Conditions2

Locations1 site

Find trials near these locations

Browse More Trials